Price
$1.79
Increased by +2.29%
Dollar Volume
330.81 K
ADR%
13.38
Earnings Report Date (estimate)
Mar 28, 23 (-0.72)
Market Cap.
50.93 M
Shares Float
20.73 M
Shares Outstanding
28.45 M
Beta
0.65
Price / Earnings
-0.40
BPR
502.08
20D Range
0.94 1.93
50D Range
0.63 1.93
200D Range
0.48 2.15
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Nov 10, 22 -0.72
Increased by +29.41%
-0.81
Increased by +11.11%
Aug 11, 22 0.16
Increased by +115.38%
-0.80
Increased by +120.00%
Mar 30, 22 -1.12
Decreased by -6.67%
-0.83
Decreased by -34.94%
Nov 11, 21 -0.94
Increased by +51.79%
-0.87
Decreased by -8.05%
Aug 12, 21 -1.02
Increased by +96.84%
-0.84
Decreased by -21.43%
May 12, 21 -1.04
Increased by +98.71%
-0.81
Decreased by -28.40%
Mar 18, 21 -1.05 -0.72
Decreased by -45.83%
Nov 12, 20 -1.95 -0.99
Decreased by -96.97%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 3.64 M
Decreased by -20.80%
-20.43 M
Increased by +28.36%
Decreased by -560.51%
Increased by +9.55%
Jun 30, 22 4.08 M
Decreased by -13.44%
5.72 M
Increased by +119.90%
Increased by +140.28%
Increased by +123.00%
Mar 31, 22 3.68 M
Increased by +2.51%
-40.02 M
Decreased by -37.13%
Decreased by -1.09 K%
Decreased by -33.78%
Dec 31, 21 4.36 M
Increased by +69.46%
-31.26 M
Decreased by -6.33%
Decreased by -716.74%
Increased by +37.25%
Sep 30, 21 4.60 M
Increased by +45.00%
-28.51 M
Increased by +8.88%
Decreased by -619.67%
Increased by +37.16%
Jun 30, 21 4.71 M
Increased by +315.26%
-28.73 M
Decreased by -23.86%
Decreased by -610.04%
Increased by +70.17%
Mar 31, 21 3.59 M
Increased by +126.85%
-29.18 M
Decreased by -61.24%
Decreased by -812.61%
Increased by +28.92%
Dec 31, 20 2.57 M
Increased by +284.75%
-29.40 M
Decreased by -47.64%
Decreased by -1.14 K%
Increased by +61.63%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.